Natural Alternatives International Inc
NAIINasdaqCIK 787253HealthcareFiscal year ends Jun 30
Reports and events: 171 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2316:11 ET | DEF 14A | Proxy statementPeriod 2026-12-11 | 0001437749-26-033415 |
| 2026-09-2816:16 ET | 10-K | Annual reportPeriod 2026-06-30 | 0001437749-26-031343 |
| 2026-05-1906:03 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001437749-26-017684 |
| 2026-05-0117:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001437749-26-014497 |
| 2026-03-2016:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-26-009247 |
| 2026-02-1316:17 ET | 10-Q | Quarterly reportPeriod 2025-12-31 | 0001437749-26-004118 |
| 2025-12-1717:13 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001437749-25-038181 |
| 2025-12-1220:10 ET | 8-K | 5.07 Shareholder vote results | 0001437749-25-037601 |
| 2025-11-1216:35 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001437749-25-034473 |
| 2025-10-2316:16 ET | DEF 14A | Proxy statementPeriod 2025-12-05 | 0001437749-25-031627 |
| 2025-09-2316:16 ET | 10-K | Annual reportPeriod 2025-06-30 | 0001437749-25-029731 |
| 2025-07-2116:32 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-023101 |
| 2025-07-0116:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-25-021738 |
| 2025-06-2316:32 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-021047 |
| 2025-05-1417:19 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001437749-25-016911 |
| 2025-02-1416:15 ET | 10-Q | Quarterly reportPeriod 2024-12-31 | 0001437749-25-004002 |
| 2024-12-1016:02 ET | 8-K | 5.07 Shareholder vote results | 0001437749-24-037106 |
| 2024-11-1316:51 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001437749-24-034914 |
| 2024-11-1316:15 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001437749-24-034912 |
| 2024-10-2316:15 ET | DEF 14A | Proxy statementPeriod 2024-12-06 | 0001437749-24-031894 |
| 2024-09-2717:27 ET | 10-K | Annual reportPeriod 2024-06-30 | 0001437749-24-030208 |
| 2024-05-1416:15 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001437749-24-016627 |
| 2024-02-1316:15 ET | 10-Q | Quarterly reportPeriod 2023-12-31 | 0001437749-24-003906 |
| 2023-12-1218:35 ET | 8-K | 5.07 Shareholder vote results | 0001437749-23-034100 |
| 2023-11-0916:15 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001437749-23-031262 |
| 2023-10-2616:36 ET | DEF 14A | Proxy statementPeriod 2023-12-07 | 0001437749-23-029109 |
| 2023-09-2116:15 ET | 10-K | Annual reportPeriod 2023-06-30 | 0001437749-23-026521 |
| 2023-08-1616:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-23-023956 |
| 2023-07-2416:02 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001437749-23-020535 |
| 2023-05-1516:16 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001437749-23-014575 |
| 2023-02-0816:15 ET | 10-Q | Quarterly reportPeriod 2022-12-31 | 0001437749-23-002792 |
| 2022-12-0620:03 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-22-028466 |
| 2022-11-0916:31 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001437749-22-026615 |
| 2022-10-2517:17 ET | DEF 14A | Proxy statementPeriod 2022-12-02 | 0001437749-22-024718 |
| 2022-10-1315:27 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001437749-22-024096 |
| 2022-09-2206:03 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-22-022880 |
| 2022-09-2116:16 ET | 10-K | Annual reportPeriod 2022-06-30 | 0001437749-22-022855 |
| 2022-05-1315:16 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-22-012326 |
| 2022-05-1306:03 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001437749-22-012221 |
| 2022-02-1019:50 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-22-002917 |
| 2022-02-0916:15 ET | 10-Q | Quarterly reportPeriod 2021-12-31 | 0001437749-22-002872 |
| 2022-01-1811:51 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-22-001039 |
| 2021-12-0816:01 ET | 8-K | 5.07 Shareholder vote results | 0001437749-21-028079 |
| 2021-11-0916:16 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001437749-21-025928 |
| 2021-10-2813:40 ET | DEF 14A | Proxy statementPeriod 2021-12-03 | 0001437749-21-024499 |
| 2021-09-2118:55 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-21-022445 |
| 2021-09-2016:46 ET | 10-K | Annual reportPeriod 2021-06-30 | 0001437749-21-022419 |
| 2021-08-2406:31 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-21-020786 |
| 2021-07-0916:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-21-016717 |
| 2021-06-0917:21 ET | 8-K | 3.01 Delisting notice | 0001437749-21-014441 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:56 ET. Listed shows no prices and gives no investment advice.